» Articles » PMID: 14742502

A K+ Yptake Protein, TrkA, is Required for Serum, Protamine, and Polymyxin B Resistance in Vibrio Vulnificus

Overview
Journal Infect Immun
Date 2004 Jan 27
PMID 14742502
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Vibrio vulnificus, a highly virulent marine bacterium, is the causative agent of both serious wound infections and fatal septicemia in many areas of the world. To identify the genes required for resistance to human serum, we constructed a library of transposon mutants of V. vulnificus and screened them for hypersensitivity to human serum. Here we report that one of the isolated serum-susceptible mutants had a mutation in an open reading frame identified as trkA, a gene encoding an amino acid sequence showing high identity to that of TrkA of Vibrio alginolyticus, a protein required for the uptake of potassium. A trkA isogenic mutant was constructed via insertional inactivation, and it was significantly more easily killed by human serum, protamine, or polymyxin B than was the wild type. At K+ concentrations of 1 to 20 mM, this isogenic mutant showed attenuated growth compared to the wild-type strain. In addition, infection experiments demonstrated virulence attenuation when this mutant was administered intraperitoneally or subcutaneously to both normal and iron-treated mice, indicating that TrkA may modulate the transport of potassium and resistance to host innate defenses and that it is important for virulence in mice.

Citing Articles

Molecular Mechanisms of Bacterial Resistance to Antimicrobial Peptides in the Modern Era: An Updated Review.

Tajer L, Paillart J, Dib H, Sabatier J, Fajloun Z, Khattar Z Microorganisms. 2024; 12(7).

PMID: 39065030 PMC: 11279074. DOI: 10.3390/microorganisms12071259.


Determinants of bacterial survival and proliferation in blood.

Le-Bury P, Echenique-Rivera H, Pizarro-Cerda J, Dussurget O FEMS Microbiol Rev. 2024; 48(3).

PMID: 38734892 PMC: 11163986. DOI: 10.1093/femsre/fuae013.


Stress Responses in Pathogenic Vibrios and Their Role in Host and Environmental Survival.

Akolkar J, Matson J Adv Exp Med Biol. 2023; 1404:213-232.

PMID: 36792878 DOI: 10.1007/978-3-031-22997-8_11.


The role of bacterial transport systems in the removal of host antimicrobial peptides in Gram-negative bacteria.

Blair J, Zeth K, Bavro V, Sancho-Vaello E FEMS Microbiol Rev. 2022; 46(6).

PMID: 35749576 PMC: 9629497. DOI: 10.1093/femsre/fuac032.


Detection of Gene in Undefined Species Isolated from Clams.

Valdez C, Costa C, Simoes M, de Carvalho C, Baptista T, Campos M Microorganisms. 2022; 10(2).

PMID: 35208850 PMC: 8876837. DOI: 10.3390/microorganisms10020394.


References
1.
Wright A, Powell J, Tanner M, Ensor L, Karpas A, Morris Jr J . Differential expression of Vibrio vulnificus capsular polysaccharide. Infect Immun. 1999; 67(5):2250-7. PMC: 115964. DOI: 10.1128/IAI.67.5.2250-2257.1999. View

2.
Hancock R, Chapple D . Peptide antibiotics. Antimicrob Agents Chemother. 1999; 43(6):1317-23. PMC: 89271. DOI: 10.1128/AAC.43.6.1317. View

3.
Bisharat N, Agmon V, Finkelstein R, Raz R, Ben-Dror G, Lerner L . Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Israel Vibrio Study Group. Lancet. 1999; 354(9188):1421-4. DOI: 10.1016/s0140-6736(99)02471-x. View

4.
Shao C, Hor L . Metalloprotease is not essential for Vibrio vulnificus virulence in mice. Infect Immun. 2000; 68(6):3569-73. PMC: 97644. DOI: 10.1128/IAI.68.6.3569-3573.2000. View

5.
Chuang Y, Yuan C, Liu C, Lan C, Huang A . Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment. Clin Infect Dis. 1992; 15(2):271-6. DOI: 10.1093/clinids/15.2.271. View